GMND yields 1000000.00% · JNJ yields 2.13%● Live data
📍 GMND pulled ahead of the other in Year 1
Combined, GMND + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GMND + JNJ for your $10,000?
Green Mountain Development Corp provides project development services for capital providers and technology operators; and distributes licensed products related to the energy, agricultural, and environmental sectors. The company assists clients with preliminary development work, including project due diligence, investor presentations, identification of project capital sources and technology vendors, and negotiation of a joint venture agreement between investors and the client. It also distributes Bio-Miracle microbial blends that are used for agricultural growth enhancement, composting acceleration, pond and lake water treatment, hydrocarbon reduction in soil and water, and animal and green waste treatment. The Bio-Miracle product lines include Remediline remediation products comprising SPILL KILL PRO, an oil spill cleanup product for soil and tank applications, and SIZZLE CLEAN, a microbe water based fizzing tablet for parts cleaning applications; Wasteline waste management products consisting of MANURE KING for cow/horse/pig manure control and SPARKLE CLEAN for septic and cesspool cleanup; and Bi-Agra agricultural products for increased plant health, size, and yield improvement, such as Bi-Agra-100, Bi-Agra-200, TOO TALL TOMATOES, and COMPOST PAL for backyard and commercial composting acceleration, as well as non-invasive dethatch applications. In addition, it focuses on the research, development, and production of a range of life science products. The company is based in Carlsbad, California.
Full GMND Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.